Revised ACC/AHA HF guidelines address aldosterone, device use, quality of life

The just-released 2013 ACC/AHA HF guidelines present a strong evidence-based approach that covers the spectrum from screening for the disease, through treatments, to discussing end-of-life care. (Source: theHeart.org)

Source: http://www.medworm.com/index.php?rid=7341675&cid=u_0_7_f&fid=38373&url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1551989.do

phlebotomy classes cheap phlebotomy training phlebotomy programs